KKR, a global investment firm, agreed to invest in Catalio Capital Management, a venture capital firm. Financial terms were not disclosed. “The life sciences sector represents a growing market opportunity and has been an important area of focus for our health care growth strategy, which will be further accelerated through our partnership with Catalio. We are impressed not only by Catalio’s entrepreneurial leadership team but also by its vast network of leading scientists who serve as venture partners. We look forward to supporting Catalio in taking the platform to the next level and unlocking the next generation of biomedical technology,” Ali Satvat, KKR Partner.